BEAT_PRO Beam Tailoring and procedures optimization for clinical bnct

Slides:



Advertisements
Similar presentations
MedAustron – Austrian Hadron Therapy Centre
Advertisements

Stefan Roesler SC-RP/CERN on behalf of the CERN-SLAC RP Collaboration
Investigation of Proton Irradiation-Induced Creep of Ultrafine Grain Graphite Anne A. Campbell & Gary S. Was University of Michigan Research Supported.
UNIVERSITA’ DEGLI STUDI DI PALERMO DIN DIPARTIMENTO DI INGEGNERIA NUCLEARE CHERNE th Workshop on European Collaboration for Higher Education and.
LCSC - 01 Monte Carlo Simulation of Radiation Transport, for Stereotactic Radio Surgery Per Kjäll Elekta Instrument AB
Esteban Fabián Boggio 1 Lucas Provenzano 2 Sara Gonzalez 2,3 Sara Gonzalez 2,3 Juan Manuel Longhino 1 1 Bariloche Atomic Center, Atomic Energy National.
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Boron Neutron Capture Therapy
E. Bavarnegin,Yaser Kasesaz, H. Khalafi
Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.
Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.
Mechanical and fluidic integration of scintillating microfluidic channels into detector system 1 Davy Brouzet 10 th September 2014.
Instrumentation for medical physics applications Barbara Camanzi, PPD/RAL Instrumentation for radiotherapy Imaging: 1. Fast Time Of Flight PET 2. Electron.
Photon and Energy Fluence
Report from WP4: Applications of Accelerators AccApplic  Accelerator Applications  Aims of WP4  Workshops so far  Future workshops  Status  Plans.
A novel therapy for liver metastases: a concrete hope after the first human treatment T.Pinelli*, A.Zonta +, S. Altieri*, S.Barni ++, A.Braghieri*, P.Pedroni*,
Group Meeting – 14/6/12 Naomi Ratcliffe.
Test of the proposed method Introduction CCD Controller CCD Illuminator gel Filter 585nm Assembling the phantom before its irradiation. The phantom, ready.
First Year Workshop 2014 Miriam Lafiandra
Determination of gamma dose component in thermal column of Pavia Triga reactor by using alanine ESR detectors Saverio Altieri Department of Physics University.
ELI-NP: the way ahead, March Anna Ferrari An overview of the shielding problems around high energy laser-accelerated beams Anna Ferrari Institute.
Milestones M5 and M6 Mid-Term Review, October 2013M. Silari – ARDENT overview1 M5: comparison of detector technologies (WP1) M6: choice of detector technology.
G. Bartesaghi, 11° ICATPP, Como, 5-9 October 2009 MONTE CARLO SIMULATIONS ON NEUTRON TRANSPORT AND ABSORBED DOSE IN TISSUE-EQUIVALENT PHANTOMS EXPOSED.
Andrea Salvini, CERN, L.E.N.A. Laboratory at Pavia University (Laboratorio Energia Nucleare Applicata) TRIGA Mark II pool research reactor.
Selective Laser Sintering of Graphite Composite Bipolar Plates for PEM Fuel Cells Nannan Guo, Ming C. Leu Center for Aerospace Manufacturing Technologies,
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
Design and construction of BNCT irradiation
ARDENT Advanced Radiation Dosimetry European Network Training initiative WP1: Gas Detectors S. Rollet.
Mechanical and fluidic integration of scintillating microfluidic channels into detector system 1 Davy Brouzet 10 th September 2014.
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a wide variety of applications Cancer Therapy and UK Activities.
N. Gubanova 1, V. Kanygin 2, A. Kichigin 3, S. Taskaev 4 1 Institute of Cytology and Genetics, Novosibirsk, Russia 2 Novosibirsk State Medical University,
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
M Asnal *, T Liamsuwan 2 and T Onjun 1 1 Sirindhorn International Institute of Technology, Thammasat University 2 Nuclear Research and Development Division,
FLUKA Meeting Milan Jul 2010 Work in the frame of the LHC Phase II Upgrade Previous work was dedicated to the study of the.
Mid Term Review Meeting, 26 September 2012J. MONTAÑO1 * The research project has been supported by a Marie Curie Early Initial Training Network Fellowship.
M. Štefánik *), P. Bém, M. Honusek, K. Katovský, M. Majerle, J. Novák, and E. Šimečková AER Working Group F – „Spent Fuel Transmutation“ and INPRO IAEA.
EuCARD2  Third in a series of FP6/7 IAs on Accelerator R&D: Coordinated Accelerator Research in Europe(FP6) to coordinated by CEA - 22 partners.
1 Neutron Effective Dose calculation behind Concrete Shielding of Charge Particle Accelerators with Energy up to 100 MeV V. E Aleinikov, L. G. Beskrovnaja,
An introduction Luisella Lari On behalf of the FLUKA collaboration CAoPAC: Computer-Aided Optimization of Particle Accelerator Workshop March 2015.
1 Giuseppe G. Daquino 26 th January 2005 SoFTware Development for Experiments Group Physics Department, CERN Background radiation studies using Geant4.
Photoneutron Distributions around 18 MV X-ray Radiotherapy Accelerators using Nuclear Track Detectors Fazal-ur-Rehman, H. Al-Ghamdi, M. I. Al-Jarallah.
Investigation of 15kh2NMFAA steel and weld after irradiation in the “Korpus” facility on the RBT-6 reactor D. Kozlov, V. Golovanov, V. Raetsky, G. Shevlyakov,
WP4: Applications of Accelerators AccApplic  WP4: Applications of Accelerators  The applications  Current workshops  Future workshops  Plans EuCARD-2.
The Australian Hadron Therapy and Research Facility.
WP 7 (RDH) Detector for high intensity beam WP 6 (IRPT) New TERA chip development Leslie Karen Fanola Guarachi.
Development of Cryogenic Moderators Using a Small Proton Accelerator Yoshiaki Kiyanagi*, Fujio Hiraga, Takashi Kamiyama, Akira Homma, Fumiyuki Fujita and.
HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,
BNCT, a binary radiotherapy at cellular level
CONFIDENTIAL MATERIAL Michele Togno - II Annual ARDENT Meeting, Milan – October, 14 th D Ionization Chambers Array for Clinical Applications.
1 NANO AMPLIFIED THERAPY INFN-Milano, INFN-Torino, INFN-Pisa, INFN- Roma3, CNR-Pisa, University of Torino - Biotechnology Department.
Instrumentation for radiotherapy Imaging: 1. Fast Time Of Flight PET
Boron Neutron Capture Therapy: tecnica e sorgenti
Combined effect of charged particles irradiation and anticancer drugs in cultured tumor cells.(RDH_IRPT WP2; INFN_Milano, CNAO and Istituto Tumori) The.
GEANT4 Simulations of a Beam Shaping Assembly Design and Optimization for Thermal/Epithermal Neutrons Vahagn Ivanyan  Yerevan Physics Institute, Armenia.
Scientific investigations performed at RRC KI for
The BLAIRR Irradiation Facility Hybrid Spallation Target Optimization
National Research Center” Kurchatov Institute”
P. Buffa, S. Rizzo, E. Tomarchio
Measurements and FLUKA Simulations of Bismuth and Aluminum Activation at the CERN Shielding Benchmark Facility(CSBF) E. Iliopoulou, R. Froeschl, M. Brugger,
Diagnostics of FRIBs beam transport line
Materials for extreme thermal management (PowerMat)
International Workshop on radiosensitization
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
TCAD Simulations of Silicon Detectors operating at High Fluences D
Milan Brumovsky, Milos Kytka, Milan Marek, Petr Novosad
Russian Research Center “ Kurchatov Institute”
Design of A New Wide-dynamic-range Neutron Spectrometer for BNCT with Liquid Moderator and Absorber S. Tamaki1, I. Murata1 1. Division of Electrical,
Presentation transcript:

BEAT_PRO Beam Tailoring and procedures optimization for clinical bnct Silva Bortolussi BNCT group, Pavia CNS 5 - Lecce – 26/09/2016 http://www.bnct.it

THE CONTEXT BEAT_PRO is a part of the project for a BNCT facility at CNAO. CNAO phase II will be the first centre in the world offering three types of experimental particle therapy. INFN RFQ accelerator, coupled with a Be target, can deliver a suitable neutron beam for BNCT. Neutron beams have been tailored and tested by Treatment Planning simulation.

BNCT@CNAO WITH RFQ

BNCT@CNAO WITH RFQ

BEAM SHAPING ASSEMBLY Li + AlF3 Neutron spectrum for deep-seated tumours p+

BEAT_PRO Beam Tailoring Computational Dosimetry Treatment Planning Development of new materials for BSA (i.e. solid AlF3) Test of new material under neutron irradiation (activation + moderation performance) Simulations validation Computational Dosimetry New formalism for mixed-field dosimetry Treatment Planning Patients with different kinds of tumours Combination of BNCT and Charged Particle therapy NEW MATERIAL FOR A COMPACT AND EFFICIENT BSA NEW RADIOBIOLOGICAL MODELS AND BIOLOGIALLY WEIGHTED DOSE NEW TARGETS FOR BCNT BNCT + CARBON ION THERAPY

year I After discussion with referees: WP1-1 production of solid aluminum fluoride WP1-2 test of activation and mechanical properties after irradiation WP1-3 preparation of a representative unit of BSA to be irradiated @CN (LNL)

WP1-1 production of solid aluminum fluoride Production of small quantities of solid AlF3 by syntherization at the Department of Chemistry of University of Pavia, studying the temperature/pressure combination. Possibility to adapt the device currently producing ceramic materials for this purpose. Goal: good mechanical properties (resistance, uniformity) and high density → COMPACTNESS OF BSA Test with AlF3 of different purities chemical grade, intermediate and industrial Test with addition of different % of Li Goal: ONLY ONE MATERIAL FOR BSA

WP1-2 test of activation and mechanical properties after irradiation Irradiation of the samples at the TRIGA reactor: Thermal Column: thermal neutron irradiation for activation studies Central Channel: fast neutron irradiation for test of radiation damages Goal: investigate the influence of impurities on the security (activation) and the resistance of the material after the irradiation with high neutron/gamma fluences

WP1-3 preparation of a small prototype to be irradiated @CN (LNL) Modification of the set-up of the syntherization device to obtain larger volumes of solid AlF3 Circuit for oil pressure, load cell, feedback mechanism, Cu-Be pistons Production of graphite molds Design of molds to allow a more uniform distribution of temperature. Rectangular molds. Production of bricks to form a small prototype of some cm/side Goal: production of a representative unit of moderator material for the final BSA. This prototype will be irradiated at the CN facility (LNL), with a neutron beam produced from a Be target. The simulations will be validated by the experimental double differential spectra.

MILESTONES M1 Production of a small sample of solid AlF3, activation test and test of the mechanical properties after neutron irradiation. Production of a representative unit of moderator material for the final BSA – September 2017   M2 Calculation of treatment planning of different tumours relevant for BNCT and hadron therapy using the photon isoeffective model. Comparison of dose distribution obtained by BNCT and by carbon ion beams in some relevant examples – end of year 2 M3 Production of a small BSA prototype, with good mechanical properties and tested neutron interaction characteristics. Measurement with neutron telescope of the double differential spectrum emerging from the BSA – end year 3

GANTT M1 M3 M2 Y1Q1 Y1Q2 Y1Q3 Y2Q2 Y2Q3 Y3Q1 Y3Q2 Y3Q3 WP1-1 WP1-2   Y1Q1 Y1Q2 Y1Q3 Y2Q2 Y2Q3 Y3Q1 Y3Q2 Y3Q3 WP1-1 WP1-2 WP1-3  M1 WP1-4 WP1-5 WP1-6 M3 WP2-1 WP2-2 WP2-3 M2 WP2-4 WP2-5

PEOPLE PAVIA Silva Bortolussi Saverio Altieri Ian Postuma   Silva Bortolussi 50% Responsabile Nazionale Saverio Altieri Responsabile Locale Ian Postuma 100% Setareh Fatemi Nicoletta Protti 70% Valerio Vercesi 10% Umberto Anselmi Tamburini Cinzia Ferrari Stefano Agosteo 30% INFN Milano

FUNDS (INFN-CNSV) – YEAR 1 After discussion with referees: Consumables 10 kEu AlF3 different purities Set-up of device to produce solid AlF3 Travels 2 kEu Services 3 kEu Neutron irradiation Total year 1 15 kEu

FUNDS (EXTERNAL): NEU_BEAT

FUNDS (EXTERNAL): NEU_BEAT NEU_BEAT wants to study different strategies to produce epithermal neutron beams for BNCT, using different targets, different proton energies and different moderating materials for the BSA. Moreover, it aims at establishing some benchmark procedures in the field of computational dosimetry and treatment planning. The possibility to produce a new material based on AlF3, is an important point also for NEU_BEAT, thus part of the funds assigned to NEU_BEAT can be used to complete the set-up of a prototype for the syntherization.

Conclusions RELEVANCE of the 1° MILESTONE: possibility to obtain a SOLID and COMPACT material for the BSA. This would be of great interest also for other groups establishing accelerator-based facilities (i.e. in Okayama, Japan: BNCT facility with gantry). AFTER the first milestone, BEAT_PRO wants to study the TREATMENT PLANNING OF REAL PATIENTS in collaboration with CNAO radiotherapists. For the first time, the possibility to COMBINE BNCT and carbon ion therapy will be studied from the point of view of combined dosimetry. NEW RADIOBIOLOGICAL MODELS will be applied to calculate dose in collaboration with CNEA- Argentina.

Fixed term Researcher Unit of Pavia

Backup

WP1 – BSA (cont.) WP2 TPS + DOSIMETRY WP1-4 measurements of neutron spectrum without moderator and with different thickness of moderator WP1-5 simulation validation WP1-6 construction of a small prototype of the complete BSA WP2 TPS + DOSIMETRY WP2-1 collection of a set of relevant clinical cases (PV+CNAO) WP2-2 TP and feasibility study for different kinds of tumours (PV+CNEA) WP2-3 Dose calculations with iso-effective model (PV+CNEA) WP2-4 Comparison of dose distribution in relevant cases already treated with charged particles (PV+CNEA+CNAO) WP2-5 Simulation of treatment BNCT + charged particles (PV+CNEA+CNAO)

COSTI